Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice, Jojima T, Uchida KAkimoto KTomotsune TYanagi KIijima TSuzuki KKasai KAso Y, Atherosclerosis, 261, 44-51, Jun. 2017